We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Minimally Invasive Surgery Reduces Risk of Hospital-Acquired Infections

By HospiMedica staff writers
Posted on 23 Apr 2008
Laparoscopic surgery reduces the risk of nosocomial infections by half when compared to open surgery, according to a new study.

Researchers at California Pacific Medical Center (CPMC, San Francisco, USA) conducted a retrospective study of more than 11,000 patients that had undergone laparoscopic or open hysterectomy (43.3% of patients), gallbladder removal (32.7%), and appendectomy (24%), between September 1, 2004 and December 31, 2006, at 22 hospitals across the United States. More...
The study utilized the Nosocomial Infection Marker (NIM) to measure infection (in a previous multi-hospital study, the NIM algorithm identified nosocomial infections with 86% sensitivity and 98.5% specificity).

The results showed that 337 patients (2.89%) experienced at least one nosocomial infection. Overall, infection rates were nearly twice as high for open procedures (4.09%) than for laparoscopic procedures (2.11%). Laparoscopic surgery was associated with reduction of the risk of nosocomial infections during gallbladder removal by 66% and during hysterectomy by 52%, compared to open surgery. The study showed the reduction rates of nosocomial infections during laparoscopic appendectomy were not statistically significant. The study also discovered that 40% of the infections identified occurred within 30 days after hospital discharge. The study was published in the April 2008 edition of Surgical Endoscopy.

"This study gives more definitive evidence that laparoscopic surgery reduces the risk of nosocomial infection compared to open surgery, which may lead to improved patient care and potential reductions in costs to the healthcare system, " said lead author Andrew Brill, M.D., director of minimally invasive gynecology at CPMC.

Study results also showed that laparoscopic surgery was associated with a reduction in the overall odds ratio for each type of nosocomial infection. Compared to open surgery, patients in the study who underwent laparoscopic surgery experienced 80% reduction in the odds of respiratory tract infection, 69% reduction in bloodstream infection, 59% reduction in wound infection, 39% reduction in urinary tract infection, and a 48% reduction in other types of nosocomial infections across hysterectomies, cholecystectomies, and appendectomies.


Related Links:
California Pacific Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.